$AZO

AutoZone In, SpaceX Out: HALX’s New Rebalance

The Tuttle Capital Heavy Assets Low Obsolescence Index (HALX) was rebalanced, adding AutoZone, United Therapeutics, and others, while removing SpaceX and four other companies. The index focuses on firms with heavy assets and low AI disruption risk, potentially benefiting investors concerned about AI's impact.

Original reporting
Published Sep 21, 2026, 8:16 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 21, 2026, 9:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$AZO
Bullish
medium confidence
Mentioned
$AZO · $UTHR · $MTD · $NI · $CPRT · $AEP
Relevance
6/10
AlphAI data visualization · based on etfdb.com
Decision brief

The 30-second read

$AZOBullishMed
01

Why it matters

Inclusion or exclusion can cause short‑term price moves as index funds trade, but long‑term impact depends on underlying fundamentals.

02

Market read

The rebalance creates trading opportunities for the eight listed U.S. stocks as passive fund flows adjust.

03

What to watch

Potential liquidity constraints of HALX may limit the magnitude of price moves from the rebalance.

Relevance 6/10Novelty 6/10Timing: post‑rebalance today

Background

ETF index rebalances periodically adjust holdings to maintain strategy criteria; HALX targets heavy‑asset, low‑obsolescence companies.

Company-level read

Ticker impact

$AZOBullishMedium confidence
Context

AutoZone was added to the Tuttle Capital Heavy Assets Low Obsolescence ETF (HALX) in the latest index rebalance.

Expected impact

Small upward pressure on AZO price.

Evidence & confidence

Inclusion in a low‑obsolescence ETF may attract passive capital.

$UTHRBullishMedium confidence
Context

United Therapeutics was added to HALX in the recent rebalance.

Expected impact

Slight price increase expected.

Evidence & confidence

ETF addition creates new demand for shares.

$MTDBullishMedium confidence
Context

Mettler‑Toledo was added to HALX in the latest index rebalance.

Expected impact

Minor upside potential.

Evidence & confidence

Passive fund purchases can lift price modestly.

$NIBullishMedium confidence
Context

NiSource was added to HALX in the recent rebalance.

Expected impact

Small upward move likely.

Evidence & confidence

Utility inclusion in a low‑obsolescence ETF attracts passive inflows.

$CPRTBullishMedium confidence
Context

Copart was added to HALX in the latest index rebalance.

Expected impact

Slight price rise expected.

Evidence & confidence

New exposure for index‑tracking funds.

$AEPBearishMedium confidence
Context

American Electric Power was removed from HALX in the latest index rebalance.

Expected impact

Potential short‑term downside.

Evidence & confidence

ETF may divest, creating temporary sell pressure.

$WYBearishMedium confidence
Context

Weyerhaeuser was removed from HALX in the recent rebalance.

Expected impact

Small downside risk.

Evidence & confidence

Index removal can lead to short‑term price dip.

$JBHTBearishMedium confidence
Context

J.B. Hunt was removed from HALX in the latest index rebalance.

Expected impact

Minor decline possible.

Evidence & confidence

ETF removal often triggers modest sell‑off.

Market effects

The rebalance highlights a tilt toward low‑AI‑disruption assets, favoring industrial, utility and healthcare names.

U.S. equity markets may see modest flows into the added stocks, while removed names could face short‑term pressure.

Limited to U.S. investors tracking HALX; broader market impact is minimal.

Counterpoint

The index's low‑obsolescence focus may overlook growth opportunities, so added stocks could underperform broader market.

Key entities

  • Tuttle Capital

    Provider of the HALX ETF and its underlying index.

  • HALX

    Tuttle Capital Heavy Assets Low Obsolescence ETF.

Related articles

$KNXMed

Trucking’s “Ruthless” vs. “Conservative:” Who’s Winning?

Knight-Swift's aggressive strategy, including shedding unprofitable freight, led to an 89 operating ratio, outperforming J.B. Hunt's more conservative approach in a lukewarm freight market. Experts attribute Knight-Swift's success to its entrepreneurial culture, while J.B. Hunt's focus on dedicated and contract business limits its ability to quickly adjust to market changes. Norfolk Southern shares traded above Union Pacific's offer price, reflecting market expectations of a merger approval.

$UTHRHigh

United Therapeutics Authorizes Up to $2 Billion Share Repurchase

United Therapeutics authorized a $2 billion share repurchase program, valid until October 21, 2027. The board approved the plan on October 21, 2026. Repurchases can occur via open-market, private, or accelerated transactions, with no minimum purchase requirements. The program does not affect an ongoing accelerated repurchase from September. According to the company, it may start or suspend repurchases at any time.